Skip to Main Content
 Search | Directories | Reference Tools
UW Home > UWIN > Research > HSD 
Human Subjects Division

Learn more about the Accreditation Process for the UW Human Research Protection Program at HSD name=

FOR: | | | |
Forms
sitemap | contact hsd | glossary


 

Consent Form Language and Readability

The following information is provided to investigators to assist in the preparation of consent forms using language that potential research subjects can understand.

The University of Washington Human Subjects Manual (Part D.3.b.i., page 5,) states that informed consent must be written "in language readily understandable to potential subjects." The language must be tailored for the intended audience. Potential subjects drawn from a pool of university students can be assumed to have a reading ability at grade level 12 or better. But subjects recruited through a city newspaper, for example, cannot be assumed to have such a high reading level. The average reading level in the city of Seattle is reported to be at grade 6. Some populations may have a lower reading level or may, in fact, be illiterate.

Illiterate subjects:

Subjects who cannot read at a functional level, but wish to participate in research, may be consented orally as long as the consent process is witnessed and they sign their name (or make their mark) on the consent form.

Subjects for whom English is not a first spoken language:

Consent forms should be presented to potential subjects in their first language. If this is not feasible, a competent translator should be available to translate the consent form orally into the subject's native language. It is the responsibility of the investigator to assure that the translator can accurately translate both the consent form and questions and answers about the research between the subject and the investigator.

There are several tests investigators can use, such as the Frye test, while drafting their consent forms to make sure that the language is not too complex.

Sample Consent Form Statements - Original and Revisions

PURPOSE OF RESEARCH

Original: This is an optional, volunteer research study, the purpose of which is to improve our understanding of the risks and mechanisms of transmission of hepatitis C virus in patients receiving hemodialysis for chronic renal disease. [Grade 20]

Revised: The purpose of this research is to learn more about how a disease called Hepatitis C is spread. We want to study people who are on renal dialysis to see if they have this disease. We want to see if we can figure out how they got it. [Grade 6]

Original: Surgical correction of a skeletal disharmony with orthodontics and orthognathic surgery has become the standard of care in certain malocclusions. [ Grade 17]

Revised: Dentists often use surgery to correct bone structure in the mouth and face. [ Grade 7]

Original: The purpose of this project is to study the safety and effectiveness of an investigational new X preparation that has undergone heat treatment to reduce the likelihood of transmitting viruses causing hepatitis or other viral illnesses. [Grade 22]

Revised: Sometimes medicines can have viruses in them. People who take the medicine can then get the virus. For example, sometimes people who take X can get hepatitis. The purpose of this study is to test a new kind of X. We have treated it with heat to try to reduce the chance that it will contain hepatitis virus. We want to see if the drug is safe and effective. [Grade 7]

STUDY PROCEDURES

Original: The choice of whether you receive the medication or the placebo is made randomly and neither you nor the investigator will know the identity of the solution used. [Grade 15]

Revised: Half of the people in this study will get X. Half will get "placebo" -- drops that look like X but which have no active medicine in them. We will make the decision about who will get X and who will get the placebo by chance, like flipping a coin. Neither you nor the researcher will know which one you get. [Grade 7]

Original: If you agree to take part in this day-long study, the physician investigator will examine your throat with a standard light to see if it is normal and with an ultraviolet light to make sure there is no fluorescent material present; and examine your ears, and clear the ear canal if necessary, to determine if the tube is open and there is no infection in the ear. [Grade 14]

Revised: This study will take one day. First, the researcher will look at your throat with a standard light and with an ultraviolet light. Then he will look into your ears. He will clean your ear canal, if necessary. If you have an infection in your ears, you will not be able to take part in the study. [Grade 4]

Original: One venous blood draw of 49 ml will be taken for the above tests. The skin biopsy is done by a physician who puts the biopsy site under local anesthesia (lidocaine) and uses a 6 mm biopsy punch (6 mm across, 2-3 mm deep) to remove the skin sample. The physician will close the biopsy site with two sutures (stitches). [Grade 9]

Revised: We will take about 10 teaspoons of blood from a vein in your arm for tests. We will also take a small piece of skin (a biopsy) from under your arm. First we will numb the skin with lidocaine. Then we will use a punch machine to take a piece of skin about the size of a pea. We will close the wound with two stitches. [Grade 3]


CONFIDENTIALITY

Original: The patient's identity will remain confidential with respect to unauthorized personnel. As with every study involving an investigational new drug, the FDA will have access to study data which may contain identifying information. The manufacturer of the experimental X preparation will have access to the study data; the identifying information provided will contain only initials and unidentifying numbers. [Grade 16]

Revised: Your identity will remain private. Only the researchers, the FDA, and the company that makes X will know that you took part in this study. We will remove your name from your study records and replace your name with a code number. [Grade 7]

ADVERSE EVENTS

Original: If you suffer an adverse event as a result of study participation, you will be treated by the investigators or referred for treatment. The costs of this treatment will be covered by X, the sponsor of this study, if the investigator has not deviated from the protocol and if you have been compliant with study procedures. Payment will be made over and beyond your third party carrier or other government or non-governmental payer. No other compensation is available. [Grade 12]

Revised: If you are hurt as a result of taking part in this study, we will treat you or refer you for treatment. We will not charge you for this treatment. [Grade 4]


COMPENSATION

Original: As a token of our appreciation, we will give you a parking voucher if you parked at the University of Washington, and your child will receive a small toy and stickers.

Revised: If you park at the University of Washington, we will give you a parking voucher. As a token of our appreciation, we will give your child a small toy and some stickers.